Vista Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
4,619
-54
-1% -$29.3K 0.76% 39
2025
Q4
$2.71M Sell
4,673
-50
-1% -$28.3K 0.89% 36
2025
Q3
$2.29M Sell
4,723
-2
-0% -$931 0.8% 40
2025
Q2
$1.92M Sell
4,725
-48
-1% -$20.1K 0.71% 42
2025
Q1
$2.38M Sell
4,773
-90
-2% -$48.7K 0.93% 29
2024
Q4
$2.53M Sell
4,863
-131
-3% -$72K 0.96% 32
2024
Q3
$3.09M Sell
4,994
-83
-2% -$49.1K 1.16% 26
2024
Q2
$2.81M Buy
5,077
+86
+2% +$49.3K 1.14% 24
2024
Q1
$2.9M Sell
4,991
-10
-0.2% -$5.61K 1.18% 25
2023
Q4
$2.65M Buy
5,001
+228
+5% +$110K 1.23% 21
2023
Q3
$2.42M Buy
4,773
+60
+1% +$32K 1.27% 19
2023
Q2
$2.46M Buy
4,713
+231
+5% +$125K 1.24% 20
2023
Q1
$2.58M Sell
4,482
-24
-0.5% -$13.5K 1.37% 16
2022
Q4
$2.48M Buy
4,506
+100
+2% +$53K 1.42% 16
2022
Q3
$2.23M Sell
4,406
-33
-0.7% -$18.5K 1.38% 18
2022
Q2
$2.41M Sell
4,439
-26
-0.6% -$14.3K 1.46% 16
2022
Q1
$2.64M Sell
4,465
-2
-0% -$1.15K 1.44% 15
2021
Q4
$2.98M Sell
4,467
-121
-3% -$75.5K 1.62% 14
2021
Q3
$2.62M Sell
4,588
-85
-2% -$46.7K 1.54% 14
2021
Q2
$2.36M Sell
4,673
-49
-1% -$23.1K 1.39% 17
2021
Q1
$2.15M Sell
4,722
-101
-2% -$48.2K 1.34% 19
2020
Q4
$2.25M Sell
4,823
-556
-10% -$261K 1.51% 18
2020
Q3
$2.38M Sell
5,379
-380
-7% -$157K 1.81% 11
2020
Q2
$2.09M Sell
5,759
-354
-6% -$119K 1.79% 13
2020
Q1
$1.73M Sell
6,113
-187
-3% -$59K 1.77% 13
2019
Q4
$2.05M Sell
6,300
-190
-3% -$57.6K 1.54% 13
2019
Q3
$1.89M Sell
6,490
-78
-1% -$22.3K 1.56% 16
2019
Q2
$1.93M Sell
6,568
-350
-5% -$96.4K 1.63% 13
2019
Q1
$1.89M Sell
6,918
-340
-5% -$84.6K 1.66% 15
2018
Q4
$1.62M Sell
7,258
-160
-2% -$37.5K 1.67% 10
2018
Q3
$1.81M Sell
7,418
-58
-0.8% -$13.3K 1.6% 11
2018
Q2
$1.55M Sell
7,476
-32
-0.4% -$6.79K 1.51% 12
2018
Q1
$1.55M Hold
7,508
1.62% 11
2017
Q4
$1.43M Buy
+7,508
New +$1.44M 1.49% 17

Other funds holding TMO

Vista Investment Management's TMO Position: Q1 2026 in Review

Vista Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $29.3K and leaving 4,619 shares worth $2.27M. The position accounts for 0.76% of the portfolio, ranked #39.

Vista Investment Management first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.09M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Vista Investment Management held 4,619 shares of Thermo Fisher Scientific worth $2.27M as of Q1 2026.
  • Vista Investment Management sold 54 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3K.
  • Thermo Fisher Scientific made up 0.76% of Vista Investment Management's portfolio in Q1 2026, its #39 holding.
  • Vista Investment Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
  • Vista Investment Management's Thermo Fisher Scientific position peaked at $3.09M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Vista Investment Management's 13F filing for Q1 2026, filed 15 May 2026.